| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2025 | Apr 1, 2025 | Perspective Therapeutics, Inc. | CFO | Buy | 95.0 | +33,333 | 1649.33% | ✗ | $74.9K |
| Dec 6, 2024 | Dec 9, 2024 | FIBROGEN INC | CFO | Sell | 27.5 | -2,512 | -1.50% | ✗ | $859.4 |
| Sep 6, 2024 | Sep 9, 2024 | FIBROGEN INC | CFO | Sell | 27.5 | -17,115 | -9.28% | ✗ | $6.7K |
| Jun 6, 2024 | Jun 10, 2024 | FIBROGEN INC | CFO | Sell | 26.3 | -18,979 | -9.33% | ✗ | $22.5K |
| Mar 6, 2024 | Mar 8, 2024 | FIBROGEN INC | CFO | Sell | 26.3 | -21,149 | -9.42% | ✗ | $40.9K |
| Dec 6, 2023 | Dec 11, 2023 | FIBROGEN INC | CFO | Sell | 27.5 | -16,658 | -8.80% | ✗ | $9.7K |
| Sep 6, 2023 | Sep 8, 2023 | FIBROGEN INC | CFO | Sell | 37.5 | -1,807 | -0.95% | ✗ | $1.8K |
| Jun 7, 2023 | Jun 9, 2023 | FIBROGEN INC | CFO | Sell | 26.3 | -1,785 | -2.45% | ✗ | $30.3K |
| Mar 8, 2023 | Mar 10, 2023 | FIBROGEN INC | CFO | Sell | 47.5 | -94 | -0.13% | ✗ | $157.4K |
| Dec 9, 2022 | Dec 15, 2022 | FIBROGEN INC | CFO | Sell | 41.3 | -2,188 | -4.36% | ✓ | $32K |
| Dec 8, 2022 | Dec 15, 2022 | FIBROGEN INC | CFO | Sell | 25.0 | -5,741 | -10.27% | ✓ | $85.5K |
| Dec 9, 2022 | Dec 14, 2022 | FIBROGEN INC | CFO | Sell | 41.3 | -2,188 | -3.91% | ✓ | $32K |
| Sep 7, 2022 | Sep 8, 2022 | FIBROGEN INC | CFO | Sell | 26.3 | -3,009 | -5.11% | ✗ | $38K |